Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ELUT

Elutia (ELUT)

Elutia Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELUT
DateTimeSourceHeadlineSymbolCompany
19/06/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202422:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
17/06/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202422:01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
17/06/202422:00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
11/06/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
11/06/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
11/06/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
08/06/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
14/05/202407:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
13/05/202422:00GlobeNewswire Inc.Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024NASDAQ:ELUTElutia Inc
10/05/202407:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
10/05/202406:05GlobeNewswire Inc.Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceNASDAQ:ELUTElutia Inc
03/05/202406:05GlobeNewswire Inc.Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ELUTElutia Inc
25/04/202406:05GlobeNewswire Inc.Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1NASDAQ:ELUTElutia Inc
12/03/202400:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELUTElutia Inc
08/03/202408:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
08/03/202408:05GlobeNewswire Inc.Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024NASDAQ:ELUTElutia Inc
23/02/202408:05GlobeNewswire Inc.Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024NASDAQ:ELUTElutia Inc
15/02/202408:40Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
03/02/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
26/01/202408:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELUTElutia Inc
13/01/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
11/01/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
11/01/202408:05GlobeNewswire Inc.Elutia Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ELUTElutia Inc
10/01/202408:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELUTElutia Inc
09/01/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
28/12/202308:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
19/12/202300:00GlobeNewswire Inc.Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA ClearanceNASDAQ:ELUTElutia Inc
09/12/202308:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT

Your Recent History

Delayed Upgrade Clock